Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Shares Repurchased (2022)

Historic Shares Repurchased for Viking Therapeutics (VKTX) over the last 2 years, with Q2 2022 value amounting to $1.7 million.

  • Viking Therapeutics' Shares Repurchased changed N/A to $1.7 million in Q2 2022 from the same period last year, while for Dec 2022 it was $6.8 million, marking a year-over-year change of. This contributed to the annual value of $6.8 million for FY2022, which is N/A changed from last year.
  • Viking Therapeutics' Shares Repurchased amounted to $1.7 million in Q2 2022.
  • In the past 5 years, Viking Therapeutics' Shares Repurchased ranged from a high of $5.1 million in Q1 2022 and a low of $1.7 million during Q2 2022